Medibank Pvt (ASX:MPL) ROC (Joel Greenblatt) %: % (As of Dec. 2025)


ASX:MPL Medibank Pvt Ltd ASX:MPL
77 GF Score
Price A$5.00
GF Value A$4.39
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is Medibank Pvt ROC (Joel Greenblatt) %?

Medibank Pvt ASX:MPL +0.20% 77 ROC (Joel Greenblatt) % is % as of Dec. 2025. GuruFocus rates ASX:MPL with a GF Score™ of 77/100 and a GF Value™ of A$4.39 (Modestly Overvalued). The stock has 6 warning signs investors should review. Among 64 Insurance companies, Medibank Pvt ranks worse than 1562498.44% on this metric.

ROC (Joel Greenblatt) % does not apply to banks and insurance companies.

ASX:MPL
77GF Score
Medibank Pvt Ltd ASX:MPL
ROC (Joel Greenblatt) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a ROC (Joel Greenblatt) % of % mean?
Medibank Pvt (ASX:MPL) has a ROC (Joel Greenblatt) % of % as of Dec. 2025. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Medibank Pvt and its competitors. According to the industry distribution chart, Medibank Pvt ranks #999999 out of 64 companies in the Insurance industry.
Is Medibank Pvt's ROC (Joel Greenblatt) % too high?
Medibank Pvt's current ROC (Joel Greenblatt) % is %. Based on the distribution chart, Medibank Pvt ranks #999999 out of 64 companies in the Insurance industry, which is in the bottom quartile relative to peers. Overall, Medibank Pvt has a GF Score™ of 77/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Medibank Pvt's ROC (Joel Greenblatt) % compare to FNF and AXS?
According to the Insurance industry distribution chart, Medibank Pvt ranks #999999 out of 64 companies for ROC (Joel Greenblatt) %. This places Medibank Pvt in the lower half of its industry. The industry median ROC (Joel Greenblatt) % is 77.21. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for an Insurance company?
The median ROC (Joel Greenblatt) % among Insurance companies is 77.21, based on 64 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Medibank Pvt and its competitors. For the Insurance industry, the median ROC (Joel Greenblatt) % is 77.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medibank Pvt's current ROC (Joel Greenblatt) % is %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medibank Pvt stock overvalued right now?
Based on GuruFocus' analysis, Medibank Pvt (ASX:MPL) is currently considered Modestly Overvalued. The stock's GF Value™ is A$4.39, compared to a current price of A$5.00 — trading 13.9% above its estimated fair value. The current ROC (Joel Greenblatt) % is %. Medibank Pvt's overall GF Score™ is 77/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Medibank Pvt (ASX:MPL), the current ROC (Joel Greenblatt) % is % as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medibank Pvt (ASX:MPL) Overvalued in 2026?

Based on GuruFocus' analysis, Medibank Pvt stock appears to be overvalued. The current stock price of A$5.00 is trading 13.9% above its estimated GF Value™ of A$4.39. GuruFocus considers Medibank Pvt to be Modestly Overvalued.

Key valuation signals for ASX:MPL:

  • ROC (Joel Greenblatt) %: %
  • GF Value™: A$4.39 vs. price of A$5.00 (13.9% above fair value)
  • GF Score™: 77/100 with 6 warning signs

No single metric tells the full story. See the ASX:MPL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medibank Pvt Business Description

Other Exchanges MDBPF:USAMDBKY:USA
Address 695 Collins Street, Medibank Melbourne Hub, Level 2, Docklands, Melbourne, VIC, AUS, 3008
Previously owned by the Australian government, Medibank is the largest health insurer in Australia. Its two brands, Medibank Private and Ahm, cover around 5 million people. Medibank and Australia's fourth-largest health fund, NIB Holdings, are the only listed health insurers. In addition to private health insurance, the firm provides life, pet, and travel insurance, as well as health insurance for overseas students and temporary overseas workers. The Medibank Health division provides healthcare services to businesses, governments, and communities across Australia and New Zealand.
77GF Score

Get the complete analysis for ASX:MPL

ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$5.00
Price
A$4.39
GF Value